Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nemaura Med Inc (NQ: NMRD )

0.7517 +0.0017 (+0.23%)
Streaming Delayed Price Updated: 10:13 AM EDT, Mar 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Nemaura Med Inc

< Previous 1 2 3 4 Next >
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Participating in EF Hutton Fireside Chat
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Expands EU DuoPack Agreement by Including Insulin as Eligible Drug
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Q3 2023 Results, Provides Business Update
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Participation at MicroCap Rodeo Winter Wonderland Best Ideas 2023 Conference
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Nemaura Medical, Inc. (NASDAQ: NMRD) Featured in Coverage of The MicroCap Rodeo’s 3rd Annual Winter Wonderful and Best Ideas Investor Conference
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Secures ~$8.4M in Registered Direct Offering and Concurrent Private Placement
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Pricing of ~$8.4M Registered Direct Offering and Concurrent Private Placement
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces $500K PO from U.S. Health Provider HealthFleet
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nemaura Medical Receives First Purchase Order from U.S. Health Provider HealthFleet
From Nemaura Medical, Inc.
Via Business Wire
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Reports Promising Initial Results from UK NHS Miboko Study
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Nemaura Medical Reports Initial Patient Data from UK NHS Miboko Study that Demonstrates Weight Loss in 100% of Participants
From Nemaura Medical, Inc.
Via Business Wire
Sidoti's January Micro-Cap Conference
Via ACCESSWIRE
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Present at Sidoti & Co. Micro Cap Conference
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) CEO to Present at Planet MicroCap Showcase: Virtual 2022
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Nemaura Medical to Present at the Planet MIcroCap Showcase: Virtual 2022
From Nemaura Medical, Inc
Via Globe NewsWire
InvestorNewsBreaks – Nemaura Medical Inc.’s (NASDAQ: NMRD) Miboko Pilot Program Kicks Off in UK
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nemaura Commences Pilot Program of Miboko with the NHS in the United Kingdom
From Nemaura Medical, Inc
Via Globe NewsWire
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Fiscal Q2 2023 Results, Provides Business Update
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Nemaura Medical Reports Fiscal Second Quarter 2023 Results and Provides Business Update
From Nemaura Medical, Inc
Via Globe NewsWire
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) CEO to Present at Bernstein 2nd Annual CGM Disruptors Conference
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Nemaura Medical to Present at the Bernstein 2ND Annual CGM Disruptors Conference
From Nemaura Medical, Inc
Via Globe NewsWire
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Be Featured on the RedChip Money Report(R)
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Nemaura Medical, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
Via ACCESSWIRE
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Receives Provisional Purchase Order from Middle East Licensee
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Nemaura Receives Provisional Purchase Order from Middle East Licensee TPMENA
From Nemaura Medical, Inc
Via Globe NewsWire
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Participation at Upcoming MicroCap Rodeo Windy City Roundup
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Glyphosate
Nemaura Medical to Present at the MicroCap Rodeo Windy City Roundup 2022 Conference
From Nemaura Medical, Inc
Via Globe NewsWire
EVERSANA signs preliminary agreement for the large-scale launch of NMRD’s Diabetes Management Program in the U.S. Nemaura Medical, Inc. (NASDAQ: NMRD)
Via Get News
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Collaborates with EVERSANA(R) to Bring BEATdiabetes Solution to Market
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
60+ Companies to Present at the 2nd Annual MicroCap Rodeo - Windy City Roundup Conference on October 12th - 13th, 2022 in Chicago
Via ACCESSWIRE
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.